JP2013500256A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500256A5
JP2013500256A5 JP2012521761A JP2012521761A JP2013500256A5 JP 2013500256 A5 JP2013500256 A5 JP 2013500256A5 JP 2012521761 A JP2012521761 A JP 2012521761A JP 2012521761 A JP2012521761 A JP 2012521761A JP 2013500256 A5 JP2013500256 A5 JP 2013500256A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
poly
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012521761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500256A (ja
JP5837491B2 (ja
Filing date
Publication date
Priority claimed from US12/558,395 external-priority patent/US8173666B2/en
Application filed filed Critical
Priority claimed from PCT/US2010/042792 external-priority patent/WO2011011543A1/en
Publication of JP2013500256A publication Critical patent/JP2013500256A/ja
Publication of JP2013500256A5 publication Critical patent/JP2013500256A5/ja
Application granted granted Critical
Publication of JP5837491B2 publication Critical patent/JP5837491B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012521761A 2009-07-21 2010-07-21 オリゴマー−オピオイドアゴニスト抱合体 Expired - Fee Related JP5837491B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22739909P 2009-07-21 2009-07-21
US61/227,399 2009-07-21
US12/558,395 US8173666B2 (en) 2007-03-12 2009-09-11 Oligomer-opioid agonist conjugates
US12/558,395 2009-09-11
US35085310P 2010-06-02 2010-06-02
US61/350,853 2010-06-02
PCT/US2010/042792 WO2011011543A1 (en) 2009-07-21 2010-07-21 Oligomer-opioid agonist conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015139389A Division JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Publications (3)

Publication Number Publication Date
JP2013500256A JP2013500256A (ja) 2013-01-07
JP2013500256A5 true JP2013500256A5 (enExample) 2013-09-05
JP5837491B2 JP5837491B2 (ja) 2015-12-24

Family

ID=43499405

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012521761A Expired - Fee Related JP5837491B2 (ja) 2009-07-21 2010-07-21 オリゴマー−オピオイドアゴニスト抱合体
JP2015139389A Pending JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015139389A Pending JP2015180698A (ja) 2009-07-21 2015-07-13 オリゴマー−オピオイドアゴニスト抱合体

Country Status (9)

Country Link
EP (2) EP2628489B1 (enExample)
JP (2) JP5837491B2 (enExample)
KR (1) KR101788886B1 (enExample)
CN (1) CN102573918A (enExample)
AU (1) AU2010276244B2 (enExample)
CA (1) CA2768392C (enExample)
IL (3) IL217634B (enExample)
MX (1) MX2012000980A (enExample)
WO (1) WO2011011543A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
EA023929B1 (ru) 2010-09-30 2016-07-29 Астразенека Аб Кристаллический конъюгат налоксол-peg
CN103906522B (zh) * 2011-11-07 2017-04-12 尼克塔治疗公司 阿片激动剂化合物和止痛化合物的组合物、剂型以及共给药
US10525054B2 (en) 2011-11-07 2020-01-07 Inheris Biopharma, Inc. Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
WO2014070745A1 (en) * 2012-10-30 2014-05-08 Nektar Therapeutics Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
ITRM20130223A1 (it) * 2013-04-15 2014-10-16 Rosario Nicoletti Derivati della codeina come inibitori della glucuronazione della morfina
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
ES2809458T3 (es) 2014-07-17 2021-03-04 Pharmaceutical Manufacturing Res Services Inc Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN107019803B (zh) * 2016-01-29 2020-09-15 北京键凯科技股份有限公司 具有低成瘾作用的聚乙二醇化阿片样物质
CN107033154B (zh) 2016-02-02 2020-02-04 上海瀚迈生物医药科技有限公司 阿片受体拮抗剂缀合物及其应用
US11680137B2 (en) 2018-03-29 2023-06-20 Nof Corporation Method for purifying trityl group-containing monodispersed polyethylene glycol
CN111039764A (zh) * 2018-10-12 2020-04-21 山东大学 一种双亲乙烯衍生物及制备方法
WO2021029914A1 (en) * 2019-08-11 2021-02-18 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
CN116925105B (zh) * 2022-04-11 2025-11-25 上海瀚迈生物医药科技有限公司 阿片受体拮抗剂缀合物的固体盐型、晶型及其制备方法、组合物和用途
CN117567477A (zh) * 2023-11-15 2024-02-20 宜昌人福药业有限责任公司 一种氢吗啡酮和二氢吗啡类药物低分子聚乙二醇化物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
EP1782834A3 (en) * 2003-03-13 2007-08-01 Controlled Chemicals, Inc. Oxycodone conjugates with lower abuse potential and extended duration of action
EP2905033B1 (en) 2003-12-16 2020-09-02 Nektar Therapeutics Monodisperse PEGylated naloxol compositions
RS53937B1 (sr) * 2007-03-12 2015-08-31 Nektar Therapeutics Konjugati oligomerno-opioidnog agonista
JP5827123B2 (ja) * 2008-09-16 2015-12-02 ウェルズ ファーゴ バンク ナショナル アソシエイション 乱用の可能性が低いpeg化オピオイド

Similar Documents

Publication Publication Date Title
JP2013500256A5 (enExample)
JP2010527913A5 (enExample)
JP2012522898A5 (enExample)
JP2008525416A5 (enExample)
JP2009519243A5 (enExample)
JP2009541289A5 (enExample)
JP2011523643A5 (enExample)
JP2005532287A5 (enExample)
JP2019512492A5 (enExample)
JP2013507423A5 (enExample)
MX2010003950A (es) Derivado de amina que tiene actividad antagonista del receptor y5 de neuropeptido y (npy) y uso del mismo.
JP2010519270A5 (enExample)
JO2644B1 (en) Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use
JP2008510828A5 (enExample)
JP2012502904A5 (enExample)
JP2012515219A5 (enExample)
JP2006514626A5 (enExample)
JP2009535358A5 (enExample)
JP2012513416A5 (enExample)
JP2009530392A5 (enExample)
JP2010501478A5 (enExample)
JP2012531508A5 (enExample)
JP2014503548A5 (enExample)
JP2008266635A5 (ja) 活性エネルギー線硬化型液体組成物、水性インク及び液体カートリッジ
RU2012102774A (ru) Сополимеры, полимерные частицы, содержащие упомянутые сополимеры, и сополимерные связующие для композиций радиационно-чувствительных покрытий для негативных копировальных радиационно-чувствительных литографических печатных форм